Overview

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment will also be studied.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Apixaban
Enoxaparin
Enoxaparin sodium
Warfarin